Item 9 Labs to Present at The 13th Annual LD Micro Main Event Conference

Phoenix, AZ – December 8, 2020 – Item 9 Labs Corp. (OTCQX:INLB) (“Item 9 Labs,” or the “Company”), a vertically integrated cannabis operator that produces premium products, today announced that it will be presenting at the 13th annual LD Micro Main Event investor conference on Monday, December 14 at 11am EST. Chief Executive Officer Andrew Bowden will be presenting to a live, virtual audience.

 

Register here: ve.mysequire.com/

 

The Main Event will feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors and analysts.

 

“The time has finally come to do something different in the virtual conference world. Let’s see if we can pull off something that can be enjoyed by both executives and investors alike,” stated Chris Lahiji, Founder of LD, now a wholly owned subsidiary of SRAX, Inc.

 

The Main Event will take place on December 14th and 15th, exclusively on the Sequire Virtual Events platform.

 

View Item 9 Labs’ profile here: http://www.ldmicro.com/profile/INLB

 

About LD Micro/SEQUIRE

 

LD Micro began in 2006 with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. For more information, please visit ldmicro.com.

 

The upcoming Main Event will be highlighting a new format that will benefit both executives and the investors tuning in from all over the globe.

 

In September 2020, LD Micro. Inc. was acquired by SRAX, Inc., a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit srax.com and mysequire.com.

 

About Item 9 Labs Corp.

 

Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated multi-state cannabis operator headquartered in Arizona. The Company creates best-in-class products and canna-business solutions designed to help people become the best versions of themselves. With an award-winning CPG brand and nationally recognized application team, Item 9 Labs improves the cannabis experience while providing transparency, consistency, and well-being for those relying on them. For additional information, please visit: item9labscorp.com.

 

Forward-Looking Statement

 

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, proposed transactions that are not legally binding obligations of the company and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

Media Contact:

Item 9 Labs
Jayne Levy, Director of Communications
Email: Jayne@unityrd.com

 

Investor Contact:

ClearThink
Email: nyc@clearthink.capital

 

SOURCE: Item 9 Labs Corp.

Sign Up & Get FREE News Alerts From FNM Today!